Campylobacteriosis following immunosuppression for immune checkpoint inhibitor-related toxicity
Five patients receiving checkpoint inhibitor immunotherapy (CPI) under our care across two cancer centers over a 12-month period have subsequently developed campylobacterosis. All had received immune-suppressive treatment for CPI-related colitis in the weeks or months preceding the detection of Camp...
Saved in:
| Main Authors: | Karla A Lee, Veronique Bataille, Paul Nathan, Heather Shaw |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-10-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/8/2/e000577.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exploring molecular imaging to investigate immune checkpoint inhibitor-related toxicity
by: Rachel S van der Post, et al.
Published: (2025-05-01) -
Food, fish and campylobacteriosis
by: Alejandro de Jesús Cortés-Sánchez
Published: (2020-10-01) -
Bovine Genital Campylobacteriosis
by: Max B. Irsik, et al.
Published: (2007-04-01) -
Bovine Genital Campylobacteriosis
by: Max B. Irsik, et al.
Published: (2007-04-01) -
Bovine Genital Campylobacteriosis
by: Max B. Irsik, et al.
Published: (2007-04-01)